Privi Speciality Chemicals Ltd Q2 profit rises to ₹117.03 crore

Privi Speciality Chemicals Ltd reported consolidated net profit of ₹117.03 crore for the quarter ended September 30, 2026, compared with ₹93.91 crore a year earlier. Total income rose 13.9% year-on-year to ₹773.16 crore, while EBITDA increased 16.7% to ₹212.49 crore. The board also declared a first interim dividend of ₹5 per equity share for FY27.

What did Privi report for Q2 FY27?

Privi reported higher consolidated profit, income and EBITDA in the second quarter of FY27. Consolidated net profit stood at ₹117.03 crore, against ₹93.91 crore in the corresponding quarter of the previous financial year. The results were approved by the board at its meeting held on October 29, 2026.

The company reported total income of ₹773.16 crore for the quarter, compared with ₹678.82 crore in Q2 FY26. This represented year-on-year growth of 13.9%. The results covered the quarter and half year ended September 30, 2026, and were announced as unaudited standalone and consolidated financial results.

The quarterly update is relevant because it combines top-line growth with an increase in operating profitability. The company did not provide a separate stock-price reaction in the information available. Its financial update therefore provides the principal basis for assessing the reported quarterly performance.

How did Privi's profitability and income change?

Privi's EBITDA rose to ₹212.49 crore in Q2 FY27 from ₹182.14 crore in Q2 FY26, an increase of 16.7% year-on-year. EBITDA growth exceeded the reported 13.9% increase in total income, indicating that operating earnings grew faster than the company's top line during the quarter.

Net profit increased to ₹117.03 crore from ₹93.91 crore in the year-earlier period. The reported figures show growth at both the operating and net-profit levels, although the information provided does not set out a detailed breakup of expenses, product categories, volumes or margins.

The improvement follows growth reported in the June 2026 quarter, when Privi said consolidated net profit was ₹84.21 crore and sales were ₹666.22 crore. That earlier update had also indicated year-on-year expansion in both sales and profit. The September-quarter results extend that sequence of reported growth into the first half of FY27.

What dividend did Privi approve for FY27?

Privi approved its first interim dividend of ₹5 per equity share of face value ₹10 each for FY27. The declaration was made alongside the approval of the company's September-quarter and half-year financial results on October 29, 2026.

The company has fixed November 4, 2026, as the record date for determining shareholder eligibility for the interim dividend. It said the dividend payment would be made on or before November 25, 2026. Shareholders must hold eligible shares as of the record date under the applicable settlement and corporate-action process.

The dividend is a separate board decision from the reported quarterly profit. The available announcement does not state the aggregate dividend payout, the number of eligible shares, or whether the interim dividend establishes a policy for later distributions in FY27. Those details should not be inferred from the per-share declaration alone.

What other decisions did Privi's board take?

Privi's board also approved an investment limit of ₹2.97 crore for a Gujarat wind-solar hybrid project. The announcement said the investment limit would be updated after the execution of the relevant agreement, indicating that the disclosed amount is subject to the project's agreement process.

The board further approved an amalgamation scheme, according to the October 29 announcement. The information provided does not identify the entities involved, the terms of the scheme, its implementation timetable, or the expected financial effect. As a result, no operational or valuation impact can be quantified from the disclosed details.

The Gujarat project approval places a renewable-energy-related investment alongside the financial-results announcement. However, the company has not disclosed in the provided material the project capacity, expected commissioning date, ownership structure or potential savings. The ₹2.97 crore figure is therefore the only specified financial commitment for this proposal.

Why do Privi's Q2 results matter to investors?

Privi's Q2 FY27 results matter because total income, EBITDA and consolidated net profit all rose from the comparable quarter a year earlier. Income reached ₹773.16 crore, while EBITDA reached ₹212.49 crore and net profit reached ₹117.03 crore. These figures provide investors with a clearer view of the company's reported financial progress in the September quarter.

The faster reported growth in EBITDA than total income is an important operating measure, since EBITDA reflects earnings before interest, tax, depreciation and amortisation. But the available information does not provide enough detail to attribute this movement to any particular product segment, raw-material trend, price change or cost-control measure.

For shareholders, the ₹5-per-share interim dividend sets a near-term corporate-action date, with November 4, 2026 as the record date and payment due by November 25, 2026. For the wider industry, the update adds another data point on quarterly financial performance within the specialty chemicals space, but it does not include broader sector demand or pricing data.

Conclusion

Privi reported a stronger Q2 FY27 financial outcome, with consolidated net profit rising to ₹117.03 crore, total income increasing 13.9% to ₹773.16 crore and EBITDA growing 16.7% to ₹212.49 crore. The board paired the earnings announcement with a first interim dividend of ₹5 per share, as well as approvals related to a Gujarat wind-solar hybrid project and an amalgamation scheme.

The next disclosed dates are November 4, 2026, the record date for the interim dividend, and November 25, 2026, the deadline for its payment. Investors will also watch for further disclosures on the Gujarat project agreement and the terms, participants and implementation path of the approved amalgamation scheme.